Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2025)

Krystal Biotech (KRYS) has disclosed Exchange Rate Effect for 4 consecutive years, with -$637000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect fell 7.24% to -$637000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $286000.0 through Dec 2025, up 162.45% year-over-year, with the annual reading at $286000.0 for FY2025, 162.45% up from the prior year.
  • Exchange Rate Effect hit -$637000.0 in Q4 2025 for Krystal Biotech, down from -$307000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q2 2025 to a low of -$637000.0 in Q4 2025.
  • Historically, Exchange Rate Effect has averaged -$28384.6 across 4 years, with a median of -$36000.0 in 2023.
  • Biggest YoY gain for Exchange Rate Effect was 2283.33% in 2024; the steepest drop was 4312.5% in 2024.
  • Year by year, Exchange Rate Effect stood at -$41000.0 in 2022, then crashed by 241.46% to -$140000.0 in 2023, then tumbled by 324.29% to -$594000.0 in 2024, then decreased by 7.24% to -$637000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for KRYS at -$637000.0 in Q4 2025, -$307000.0 in Q3 2025, and $1.1 million in Q2 2025.